Ubs Group Ag Thermo Genesis Holdings, Inc. Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.18 - $11.25 $1,924 - $120,273	10,691 Added 133637.5%	10,699 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.01 - $2.03 $5,691 - $11,439	-5,635 Reduced 99.86%	8 $0
Q3 2021 Nov 15, 2021	BUY	$1.97 - $2.67 $5,003 - $6,781	2,540 Added 81.86%	5,643 $11,000
Q2 2021 Aug 13, 2021	BUY	$2.15 - $2.99 $6,654 - $9,254	3,095 Added 38687.5%	3,103 $8,000
Q1 2021 May 12, 2021	SELL	$2.19 - $3.98 $15,202 - $27,629	-6,942 Reduced 99.88%	8 $0
Q4 2020 Feb 11, 2021	BUY	$1.98 - $2.92 $13,662 - $20,148	6,900 Added 13800.0%	6,950 $14,000
Q2 2020 Jul 31, 2020	SELL	$3.36 - $12.21 $4,546 - $16,520	-1,353 Reduced 96.44%	50 $0
Q1 2020 May 01, 2020	SELL	$1.72 - $5.8 $1,253 - $4,228	-729 Reduced 34.19%	1,403 $5,000
Q4 2019 Feb 14, 2020	BUY	$2.64 - $6.6 $5,628 - $14,071	2,132 New	2,132 $9,000

Ticker THMO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,321,400
Description
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally cl...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.